Amgen Revenue 2006-2021 | AMGN

Amgen annual/quarterly revenue history and growth rate from 2006 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Amgen revenue for the quarter ending March 31, 2021 was $5.901B, a 4.22% decline year-over-year.
  • Amgen revenue for the twelve months ending March 31, 2021 was $25.164B, a 5% increase year-over-year.
  • Amgen annual revenue for 2020 was $25.424B, a 8.83% increase from 2019.
  • Amgen annual revenue for 2019 was $23.362B, a 1.62% decline from 2018.
  • Amgen annual revenue for 2018 was $23.747B, a 3.93% increase from 2017.
Amgen Annual Revenue
(Millions of US $)
2020 $25,424
2019 $23,362
2018 $23,747
2017 $22,849
2016 $22,991
2015 $21,662
2014 $20,063
2013 $18,676
2012 $17,265
2011 $15,582
2010 $15,053
2009 $14,642
2008 $15,003
2007 $14,771
2006 $14,268
2005 $12,430
Amgen Quarterly Revenue
(Millions of US $)
2021-03-31 $5,901
2020-12-31 $6,634
2020-09-30 $6,423
2020-06-30 $6,206
2020-03-31 $6,161
2019-12-31 $6,197
2019-09-30 $5,737
2019-06-30 $5,871
2019-03-31 $5,557
2018-12-31 $6,230
2018-09-30 $5,904
2018-06-30 $6,059
2018-03-31 $5,554
2017-12-31 $5,802
2017-09-30 $5,773
2017-06-30 $5,810
2017-03-31 $5,464
2016-12-31 $5,965
2016-09-30 $5,811
2016-06-30 $5,688
2016-03-31 $5,527
2015-12-31 $5,536
2015-09-30 $5,723
2015-06-30 $5,370
2015-03-31 $5,033
2014-12-31 $5,331
2014-09-30 $5,031
2014-06-30 $5,180
2014-03-31 $4,521
2013-12-31 $5,011
2013-09-30 $4,748
2013-06-30 $4,679
2013-03-31 $4,238
2012-12-31 $4,421
2012-09-30 $4,319
2012-06-30 $4,477
2012-03-31 $4,048
2011-12-31 $3,973
2011-09-30 $3,944
2011-06-30 $3,959
2011-03-31 $3,706
2010-12-31 $3,841
2010-09-30 $3,816
2010-06-30 $3,804
2010-03-31 $3,592
2009-12-31 $3,809
2009-09-30 $3,812
2009-06-30 $3,713
2009-03-31 $3,308
2008-12-31 $3,751
2008-09-30 $3,875
2008-06-30 $3,764
2008-03-31 $3,613
2007-12-31 $3,745
2007-09-30 $3,611
2007-06-30 $3,728
2007-03-31 $3,687
2006-12-31 $3,835
2006-09-30 $3,612
2006-06-30 $3,604
2006-03-31 $3,217
2005-12-31 $3,271
2005-09-30 $3,154
2005-06-30 $3,172
2005-03-31 $2,833
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $137.772B $25.424B
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $151.148B 10.06
Moderna (MRNA) United States $139.174B 277.29
CSL (CSLLY) Australia $98.453B 0.00
Gilead Sciences (GILD) United States $85.723B 8.28
BioNTech SE (BNTX) Germany $82.168B 59.58
Illumina (ILMN) United States $71.977B 103.79
Regeneron Pharmaceuticals (REGN) United States $61.490B 17.61
Vertex Pharmaceuticals (VRTX) United States $51.450B 19.99
Biogen (BIIB) United States $49.434B 13.57
BeiGene (BGNE) Cayman Islands $30.247B 0.00
Genmab (GMAB) Denmark $29.669B 34.75
Genmab (GNMSF) Denmark $29.422B 6.39
Seagen (SGEN) United States $28.062B 47.31
Horizon Therapeutics Public (HZNP) Ireland $22.427B 28.67
Alnylam Pharmaceuticals (ALNY) United States $20.918B 0.00
Bio-Rad Laboratories (BIO.B) United States $20.768B 44.27
Bio-Techne Corp (TECH) United States $18.891B 99.33
Exact Sciences (EXAS) United States $18.639B 0.00
Incyte (INCY) United States $17.257B 34.12
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $16.250B 0.00
ARGENX SE-ADR (ARGX) Netherlands $15.883B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.146B 101.86
Zai Lab (ZLAB) China $13.755B 0.00
Repligen (RGEN) United States $13.609B 103.71
Novavax (NVAX) United States $13.539B 0.00
QIAGEN (QGEN) Netherlands $12.035B 20.38
Guardant Health (GH) United States $11.382B 0.00
CureVac (CVAC) Germany $9.325B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $9.322B 23.94
Intellia Therapeutics (NTLA) United States $9.308B 0.00
Mirati Therapeutics (MRTX) United States $8.167B 0.00
Fate Therapeutics (FATE) United States $8.001B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $7.733B 0.00
Acceleron Pharma (XLRN) United States $7.570B 0.00
Ascendis Pharma (ASND) Denmark $6.478B 0.00
Legend Biotech (LEGN) United States $6.231B 0.00
I-Mab (IMAB) China $6.184B 0.00
Denali Therapeutics (DNLI) United States $6.118B 219.48
SWEDISH ORP BIO (BIOVF) Sweden $6.000B 21.50
Halozyme Therapeutics (HALO) United States $5.774B 31.68
Twist Bioscience (TWST) United States $5.749B 0.00
Beam Therapeutics (BEAM) United States $5.670B 0.00
Sarepta Therapeutics (SRPT) United States $5.472B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.455B 0.00
NeoGenomics (NEO) United States $5.434B 921.60
Exelixis (EXEL) United States $5.400B 86.15
Adaptive Biotechnologies (ADPT) United States $5.162B 0.00
Blueprint Medicines (BPMC) United States $5.095B 14.38
Apellis Pharmaceuticals (APLS) United States $5.091B 0.00
Arvinas (ARVN) United States $4.785B 0.00
Vir Biotechnology (VIR) United States $4.663B 0.00
Reata Pharmaceuticals (RETA) United States $4.622B 0.00
Alkermes (ALKS) Ireland $4.346B 128.29
AbCellera Biologics (ABCL) $4.286B 0.00
SpringWorks Therapeutics (SWTX) United States $4.185B 0.00
Galapagos (GLPG) Belgium $4.027B 0.00
Certara (CERT) United States $3.997B 0.00
Arena Pharmaceuticals (ARNA) United States $3.672B 0.00
Emergent Biosolutions (EBS) United States $3.422B 8.25
ACADIA Pharmaceuticals (ACAD) United States $3.364B 0.00
Berkeley Lights (BLI) United States $3.087B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.841B 0.00
Intra-Cellular Therapies (ITCI) United States $2.831B 0.00
Editas Medicine (EDIT) United States $2.818B 0.00
Kymera Therapeutics (KYMR) United States $2.684B 0.00
Heska (HSKA) United States $2.608B 1136.95
BAVARIAN NORDIC (BVNRY) Denmark $2.573B 0.00
Amicus Therapeutics (FOLD) United States $2.501B 0.00
Insmed (INSM) United States $2.497B 0.00
Sorrento Therapeutics (SRNE) United States $2.482B 0.00
Vericel (VCEL) United States $2.461B 663.63
ALX Oncology Holdings (ALXO) United States $2.460B 0.00
Myriad Genetics (MYGN) United States $2.378B 0.00
Prothena (PRTA) Ireland $2.330B 0.00
Atea Pharmaceuticals (AVIR) United States $2.158B 0.00
Protagonist Therapeutics (PTGX) United States $2.157B 0.00
Arcus Biosciences (RCUS) United States $2.133B 0.00
Morphic Holding (MORF) United States $2.100B 0.00
Revance Therapeutics (RVNC) United States $2.094B 0.00
Cytokinetics (CYTK) United States $2.064B 0.00
Celldex Therapeutics (CLDX) United States $2.030B 0.00
Alector (ALEC) United States $2.021B 0.00
Instil Bio (TIL) United States $1.985B 0.00
C4 Therapeutics (CCCC) United States $1.935B 0.00
Myovant Sciences (MYOV) United Kingdom $1.929B 0.00
Seer (SEER) $1.910B 0.00
Ligand Pharmaceuticals (LGND) United States $1.848B 27.06
MorphoSys AG (MOR) Germany $1.838B 0.00
Inovio Pharmaceuticals (INO) United States $1.799B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.793B 0.00
Castle Biosciences (CSTL) United States $1.748B 0.00
Global Blood Therapeutics (GBT) United States $1.728B 0.00
Bluebird Bio (BLUE) United States $1.727B 0.00
Bionano Genomics (BNGO) United States $1.681B 0.00
Amarin (AMRN) Ireland $1.666B 0.00
NGM Biopharmaceuticals (NGM) United States $1.617B 0.00
PHARMA MAR SA (PHMMF) Spain $1.585B 0.00
Avid Bioservices (CDMO) United States $1.553B 635.50
Harmony Biosciences Holdings (HRMY) United States $1.516B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.495B 0.00
Zymeworks (ZYME) Canada $1.479B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.453B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.427B 0.00
Nurix Therapeutics (NRIX) United States $1.418B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.411B 0.00
Sangamo Therapeutics (SGMO) United States $1.386B 0.00
Codexis (CDXS) United States $1.375B 0.00
PureTech Health (PRTC) United States $1.366B 0.00
MiMedx (MDXG) United States $1.366B 0.00
REGENXBIO (RGNX) United States $1.359B 0.00
Ocugen (OCGN) United States $1.358B 0.00
BioAtla (BCAB) United States $1.348B 0.00
UniQure (QURE) Netherlands $1.334B 4.54
Zealand Pharma (ZEAL) Denmark $1.316B 0.00
Genetron Holdings (GTH) China $1.306B 0.00
Repare Therapeutics (RPTX) Canada $1.244B 0.00
Scholar Rock Holding (SRRK) United States $1.182B 0.00
Agenus (AGEN) United States $1.177B 0.00
Precigen (PGEN) United States $1.158B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.133B 0.00
Dynavax Technologies (DVAX) United States $1.083B 0.00
Nkarta (NKTX) United States $1.069B 0.00
Inhibrx (INBX) United States $1.056B 0.00
Zealand Pharma (ZLDPF) Denmark $1.035B 0.00
Northwest Biotherapeutics (NWBO) United States $1.019B 0.00
MannKind (MNKD) United States $1.004B 0.00
Coherus BioSciences (CHRS) United States $0.992B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.941B 29.16
KaloBios Pharmaceuticals (HGEN) United States $0.929B 0.00
Mesoblast (MESO) Australia $0.922B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.912B 0.00
Shattuck Labs (STTK) United States $0.911B 0.00
Travere Therapeutics (TVTX) United States $0.866B 0.00
Keros Therapeutics (KROS) United States $0.840B 0.00
Prometheus Biosciences (RXDX) United States $0.834B 0.00
Sutro Biopharma (STRO) United States $0.816B 0.00
Mersana Therapeutics (MRSN) United States $0.784B 0.00
Pliant Therapeutics (PLRX) United States $0.783B 0.00
Avidity Biosciences (RNA) United States $0.776B 0.00
RAPT THERAPTICS (RAPT) United States $0.776B 0.00
IDEAYA Biosciences (IDYA) United States $0.772B 0.00
VBI Vaccines (VBIV) United States $0.770B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.744B 0.00
Kadmon Holdings (KDMN) United States $0.741B 0.00
Pharming Group (PHAR) Netherlands $0.731B 0.00
G1 THERAPEUTICS (GTHX) United States $0.724B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.723B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.720B 0.00
Pharming Group (PHGUF) Netherlands $0.720B 23.00
Adagene (ADAG) China $0.718B 0.00
Curis (CRIS) United States $0.707B 0.00
Merus (MRUS) Netherlands $0.683B 0.00
SESEN BIO, INC (SESN) United States $0.681B 0.00
Affimed (AFMD) Germany $0.679B 0.00
Epizyme (EPZM) United States $0.665B 0.00
Seres Therapeutics (MCRB) United States $0.644B 0.00
AnaptysBio (ANAB) United States $0.643B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Cellectis S.A (CLLS) France $0.620B 0.00
Akoya Biosciences (AKYA) United States $0.615B 0.00
Cara Therapeutics (CARA) United States $0.608B 52.83
ChromaDex (CDXC) United States $0.606B 0.00
MeiraGTx Holdings (MGTX) United States $0.603B 0.00
DBV Technologies S.A (DBVT) France $0.591B 0.00
Anika Therapeutics (ANIK) United States $0.579B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.576B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.573B 0.00
Precision BioSciences (DTIL) United States $0.571B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.557B 0.00
ALBIREO PHARMA (ALBO) United States $0.555B 0.00
Verastem (VSTM) United States $0.552B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.531B 0.00
Vaccitech (VACC) United Kingdom $0.530B 0.00
Clene (CLNN) United States $0.529B 0.00
VistaGen Therapeutics (VTGN) United States $0.528B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.527B 9.61
AC Immune SA (ACIU) Switzerland $0.522B 0.00
Inventiva S.A (IVA) France $0.522B 0.00
Clovis Oncology (CLVS) United States $0.514B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.496B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
XBiotech (XBIT) United States $0.480B 0.00
Cybin (CLXPF) Canada $0.473B 0.00
Compugen (CGEN) Israel $0.456B 0.00
Bolt Biotherapeutics (BOLT) United States $0.426B 0.00
Athenex (ATNX) United States $0.422B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.420B 0.00
Kindred Biosciences (KIN) United States $0.420B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.413B 0.00
ANI Pharmaceuticals (ANIP) United States $0.413B 11.39
Forte Biosciences (FBRX) United States $0.411B 0.00
Spero Therapeutics (SPRO) United States $0.410B 0.00
Selecta Biosciences (SELB) United States $0.401B 0.00
Starpharma Holdings (SPHRY) Australia $0.401B 0.00
Geron (GERN) United States $0.398B 0.00
Oncobiologics (OTLK) United States $0.392B 0.00
Codiak BioSciences (CDAK) United States $0.391B 0.00
Amryt Pharma (AMYT) United Kingdom $0.383B 0.00
BioDelivery Sciences (BDSI) United States $0.377B 15.32
BeyondSpring (BYSI) United States $0.371B 0.00
XOMA (XOMA) United States $0.366B 170.79
CytomX Therapeutics (CTMX) United States $0.365B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.353B 0.00
Athersys (ATHX) United States $0.351B 0.00
Cel-Sci (CVM) United States $0.348B 0.00
AquaBounty Technologies (AQB) United States $0.346B 0.00
SQZ Biotechnologies (SQZ) United States $0.344B 0.00
Gritstone Bio (GRTS) United States $0.340B 0.00
Cue Biopharma (CUE) United States $0.335B 0.00
Theratechnologies (THTX) Canada $0.334B 0.00
UROGEN PHARMA (URGN) United States $0.327B 0.00
Opthea (OPT) Australia $0.316B 0.00
Angion Biomedica (ANGN) United States $0.311B 0.00
Puma Biotechnology (PBYI) United States $0.310B 0.00
Fortress Biotech (FBIO) United States $0.308B 0.00
Neoleukin Therapeutics (NLTX) United States $0.304B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.301B 0.00
Clearside Biomedical (CLSD) United States $0.298B 0.00
Syros Pharmaceuticals (SYRS) United States $0.290B 0.00
WAVE Life Sciences (WVE) Singapore $0.282B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.276B 0.00
Frequency Therapeutics (FREQ) United States $0.275B 0.00
IBio (IBIO) United States $0.270B 0.00
Talis Biomedical (TLIS) United States $0.268B 0.00
Innate Pharma S.A (IPHA) France $0.264B 0.00
Prima BioMed (IMMP) Australia $0.264B 0.00
Arbutus Biopharma (ABUS) United States $0.261B 0.00
INmune Bio (INMB) United States $0.258B 0.00
Cerecor (CERC) United States $0.257B 0.00
OVID THERAPEUTC (OVID) United States $0.253B 2.49
Paratek Pharmaceuticals (PRTK) United States $0.250B 0.00
Kamada (KMDA) Israel $0.247B 16.79
Chiasma (CHMA) United States $0.241B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.239B 0.00
Fulcrum Therapeutics (FULC) United States $0.239B 0.00
Kaleido Biosciences (KLDO) $0.238B 0.00
Adicet Bio (ACET) United States $0.234B 0.00
Adverum Biotechnologies (ADVM) United States $0.233B 0.00
Kala Pharmaceuticals (KALA) United States $0.231B 0.00
Cogent Biosciences (COGT) United States $0.230B 0.00
Bellus Health (BLU) Canada $0.229B 0.00
CorMedix Inc (CRMD) United States $0.229B 0.00
Trevena (TRVN) United States $0.224B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.223B 0.00
OSMOTICA PHARM (OSMT) United States $0.213B 0.00
Checkpoint Therapeutics (CKPT) United States $0.213B 0.00
Cardiff Oncology (CRDF) United States $0.204B 0.00
ADMA Biologics Inc (ADMA) United States $0.204B 0.00
TELA Bio (TELA) United States $0.204B 0.00
HOOKIPA Pharma (HOOK) United States $0.204B 0.00
NextCure (NXTC) United States $0.193B 0.00
Beyond Air (XAIR) United States $0.181B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.180B 0.00
Biofrontera AG (BFRA) Germany $0.177B 0.00
VolitionRX (VNRX) United States $0.177B 0.00
GENFIT S.A (GNFT) France $0.176B 0.00
Aptinyx (APTX) United States $0.175B 0.00
Seelos Therapeutics (SEEL) United States $0.173B 0.00
PHASEBIO PHARMA (PHAS) United States $0.172B 0.00
Nicox SA (NICXF) France $0.171B 0.00
Erytech Pharma SA (ERYP) France $0.170B 0.00
POXEL SA FRANCE (PXXLF) France $0.170B 0.00
Strongbridge Biopharma (SBBP) United States $0.164B 0.00
Synlogic (SYBX) United States $0.162B 0.00
Exicure (XCUR) United States $0.159B 0.00
Enzo Biochem (ENZ) United States $0.159B 46.71
VTv Therapeutics (VTVT) United States $0.157B 0.00
Applied Genetic Technologies (AGTC) United States $0.156B 0.00
X4 Pharmaceuticals (XFOR) United States $0.147B 0.00
ObsEva SA (OBSV) Switzerland $0.146B 0.00
Purple Biotech (PPBT) Israel $0.143B 0.00
Eton Pharmaceuticals (ETON) United States $0.141B 0.00
Galena Biopharma (SLS) United States $0.137B 0.00
LogicBio Therapeutics (LOGC) United States $0.136B 0.00
Antibe Therapeutics (ATBPF) Canada $0.133B 0.00
ABVC BioPharma (ABVC) United States $0.132B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.131B 0.00
Cyclerion Therapeutics (CYCN) United States $0.131B 0.00
Abeona Therapeutics (ABEO) United States $0.131B 0.00
Catalyst Biosciences (CBIO) United States $0.130B 0.00
Entera Bio (ENTX) Israel $0.127B 0.00
Viridian Therapeutics (VRDN) United States $0.126B 0.00
Voyager Therapeutics (VYGR) United States $0.125B 3.22
Orgenesis (ORGS) United States $0.123B 251.00
Liquidia Technologies (LQDA) United States $0.123B 0.00
Palatin Technologies (PTN) United States $0.121B 0.00
Novogen (KZIA) Australia $0.119B 0.00
Cocrystal Pharma (COCP) United States $0.112B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.110B 0.00
Eyenovia (EYEN) United States $0.110B 0.00
Longeveron (LGVN) United States $0.107B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.106B 0.00
Pluristem Therapeutics (PSTI) Israel $0.106B 0.00
Vascular Biogenics (VBLT) Israel $0.102B 0.00
Aytu BioPharma (AYTU) United States $0.101B 0.00
Yumanity Therapeutics (YMTX) United States $0.100B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.097B 0.00
Celsion (CLSN) United States $0.097B 0.00
Leap Therapeutics (LPTX) United States $0.096B 0.00
Dyadic (DYAI) United States $0.095B 0.00
Armata Pharmaceuticals (ARMP) United States $0.095B 0.00
Liminal BioSciences (LMNL) Canada $0.089B 0.00
ARAVIVE, INC (ARAV) United States $0.088B 0.00
AEterna Zentaris (AEZS) United States $0.088B 0.00
Evofem Biosciences (EVFM) United States $0.085B 0.00
Vyant Bio (VYNT) United States $0.083B 0.00
Aptevo Therapeutics (APVO) United States $0.082B 0.00
Zosano Pharma (ZSAN) United States $0.080B 0.00
Cidara Therapeutics (CDTX) United States $0.078B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.078B 0.00
AIkido Pharma (AIKI) United States $0.077B 0.00
Adocia (ADOCY) France $0.077B 0.00
ATyr Pharma (LIFE) United States $0.075B 0.00
Evogene (EVGN) Israel $0.075B 0.00
Protalix BioTherapeutics (PLX) Israel $0.072B 0.00
Emmaus Life Sciences (EMMA) United States $0.072B 0.00
Lumos Pharma (LUMO) United States $0.070B 0.00
Organovo Holdings (ONVO) United States $0.069B 0.00
Vaccinex (VCNX) United States $0.069B 0.00
Edesa Biotech (EDSA) Canada $0.067B 0.00
DiaMedica Therapeutics (DMAC) United States $0.066B 0.00
Celyad SA (CYAD) Belgium $0.064B 0.00
Advaxis (ADXS) United States $0.064B 0.00
Alimera Sciences (ALIM) United States $0.061B 0.00
TRACON Pharmaceuticals (TCON) United States $0.059B 0.00
Cytocom (CBLI) United States $0.057B 0.00
BioCardia (BCDA) United States $0.057B 0.00
ARIDIS PHARMACT (ARDS) United States $0.056B 0.00
Cyclo Therapeutics (CYTH) United States $0.054B 0.00
Idera Pharmaceuticals (IDRA) United States $0.053B 0.00
Genetic Technologies (GENE) Australia $0.052B 0.00
Windtree Therapeutics (WINT) United States $0.051B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.048B 0.00
AnPac Bio-Medical Science (ANPC) China $0.048B 0.00
Pulmatrix (PULM) United States $0.047B 0.00
Invo BioScience (INVO) United States $0.046B 0.00
Happiness Biotech Group (HAPP) China $0.043B 0.00
Enveric Biosciences (ENVB) United States $0.041B 0.00
Soligenix (SNGX) United States $0.039B 0.00
Timber Pharmaceuticals (TMBR) United States $0.037B 0.00
Acorda Therapeutics (ACOR) United States $0.035B 0.85
Lexaria Bioscience (LEXX) Canada $0.033B 0.00
Vallon Pharmaceuticals (VLON) United States $0.031B 0.00
Prana Biotechnology (ATHE) Australia $0.030B 0.00
ThermoGenesis Holdings (THMO) United States $0.029B 0.00
GeoVax Labs (GOVX) United States $0.028B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
Benitec Biopharma (BNTC) United States $0.027B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.027B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.026B 0.00
Titan Pharmaceuticals (TTNP) United States $0.022B 0.00
ZIVO Bioscience (ZIVO) United States $0.018B 0.00
Palisade Bio (PALI) United States $0.008B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00